A Recurrent Cryptic MED14-HOXA9 Rearrangement in an Adult Patient With Mixed-Phenotype Acute Leukemia, T/myeloid, NOS by Qian Wang, Ling Zhang, Ming-qing Zhu, Zhao Zeng, Bao-zhi Fang, Jun-dan Xie, Jin-lan Pan, Chun-xiao Wu, Ni Wu, Ri Zhang, Su-ning Chen, Su-ning Chen, Hai-ping Dai, Hai-ping Dai

Get full text

Rapid Molecular Response to Dasatinib in a Pediatric Relapsed Acute Lymphoblastic Leukemia With NCOR1-LYN Fusion by Hai-Ping Dai, Hai-Ping Dai, Hai-Ping Dai, Jia Yin, Jia Yin, Jia Yin, Zheng Li, Zheng Li, Zheng Li, Chun-Xiao Yang, Tin Cao, Ping Chen, Yun-Hui Zong, Ming-Qing Zhu, Ming-Qing Zhu, Ming-Qing Zhu, Xia-Ming Zhu, Xia-Ming Zhu, Xia-Ming Zhu, Sheng Xiao, De-Pei Wu, De-Pei Wu, De-Pei Wu, Xiao-Wen Tang, Xiao-Wen Tang, Xiao-Wen Tang

Get full text

MiR-130a is aberrantly overexpressed in adult acute myeloid leukemia with t(8;21) and its suppression induces AML cell death by Chao Ding, Su-Ning Chen, Roderick A. F. Macleod, Hans G. Drexler, Stefan Nagel, De-Pei Wu, Ai-Ning Sun, Hai-Ping Dai

Get full text

Efficacy of ruxolitinib in a patient with myelodysplastic/myeloproliferative neoplasm unclassifiable and co-mutated JAK2, SF3B1 and TP53 by Qian Wang, Hai-ping Dai, Dan-dan Liu, Jun-dan Xie, Hong Yao, Zi-xuan Ding, Ting-ting Tao, Su-ning Chen, Ri Zhang

Get full text

Patients with CML in the lymphoid blastic phase have inferior response to anti‐CD19 CAR T‐cell therapy compared to de novo Ph‐positive B cell acute lymphoblastic leukemia by Mei‐Jing Liu, Kai‐Wen Tan, Han‐Yu Cao, Si‐Man Huang, Chong‐Sheng Qian, Sheng‐Li Xue, Hai‐Ping Dai, Wen‐Jie Gong

Get full text

Case Report: Blinatumomab therapy for the treatment of B-cell acute lymphoblastic leukemia patients with central nervous system infiltration by Han-Yu Cao, Han-Yu Cao, Hui Chen, Song-Bai Liu, Wen-Jie Gong, Wen-Jie Gong, Chong-Sheng Qian, Chong-Sheng Qian, Tong-Tong Zhang, Tong-Tong Zhang, Chao-Ling Wan, Chao-Ling Wan, Si-Man Huang, Si-Man Huang, Nan Xu, Hai-Ping Dai, Hai-Ping Dai, Sheng-Li Xue, Sheng-Li Xue

Get full text

CAR-T cell therapy followed by allogenic hematopoietic stem cell transplantation yielded comparable outcome between Ph like ALL and other high-risk ALL by Hai-ping Dai, Dan-qing Kong, Hong-jie Shen, Wei Cui, Qian Wang, Zheng Li, Jia Yin, Li-qing Kang, Lei Yu, De-pei Wu, Xiao-wen Tang

Get full text

Haploidentical CD7 CAR T-cells induced remission in a patient with TP53 mutated relapsed and refractory early T-cell precursor lymphoblastic leukemia/lymphoma by Hai-ping Dai, Wei Cui, Qing-ya Cui, Wen-juan Zhu, Hui-min Meng, Min-qing Zhu, Xia-ming Zhu, Lin Yang, De-pei Wu, Xiao-wen Tang

Get full text

Identification of STRBP as a Novel JAK2 Fusion Partner Gene in a Young Adult With Philadelphia Chromosome-Like B-Lymphoblastic Leukemia by Xin-Yue Zhang, Xin-Yue Zhang, Hai-Ping Dai, Hai-Ping Dai, Zheng Li, Zheng Li, Jia Yin, Jia Yin, Xing-Ping Lang, Chun-Xiao Yang, Sheng Xiao, Ming-Qing Zhu, Ming-Qing Zhu, Dan-Dan Liu, Dan-Dan Liu, Hong Liu, Hong Liu, Hong-Jie Shen, Hong-Jie Shen, De-Pei Wu, De-Pei Wu, Xiao-Wen Tang, Xiao-Wen Tang

Get full text

Efficacy and safety of cladribine, low-dose cytarabine and venetoclax in relapsed/refractory acute myeloid leukemia: results of a pilot study by Yan-Yan Li, Shuai-Shuai Ge, Yuan-Hong Huang, Ming-Zhu Xu, Chao-Ling Wan, Kai-Wen Tan, Tao Tao, Hai-Xia Zhou, Sheng-Li Xue, Hai-Ping Dai

Get full text

Preemptive inotuzumab ozogamicin eradicated measurable residual disease in Ph‐negative acute lymphoblastic leukemia relapsed post CD19 CART therapy by Si‐Man Huang, Chao‐Ling Wan, Han‐Yu Cao, Yan‐Yan Li, Chong‐Sheng Qian, Hai‐Xia Zhou, Ming‐Zhu Xu, Xiao‐Hui Hu, Lan Dai, Hai‐Ping Dai, Sheng‐Li Xue

Get full text

Efficacy and safety of decitabine combined with HAAG (homoharringtonine, aclarubicin, low-dose cytarabine and G-CSF) for newly diagnosed acute myeloid leukemia by Jun-Feng Zhu, Jun-Feng Zhu, Jun-Feng Zhu, Hai-Ping Dai, Hai-Ping Dai, Qian-Qian Zhang, Qian-Qian Zhang, Jia Yin, Jia Yin, Zheng Li, Zheng Li, Qin-Ya Cui, Qin-Ya Cui, Xiao-Peng Tian, Xiao-Peng Tian, Si-Ning Liu, Si-Ning Liu, Zheng-Ming Jin, Zheng-Ming Jin, Xia-Ming Zhu, Xia-Ming Zhu, De-Pei Wu, De-Pei Wu, Xiao-Wen Tang, Xiao-Wen Tang

Get full text

Venetoclax plus hypomethylating agents in newly diagnosed acute myeloid leukemia patients with RUNX1::RUNX1T1: a retrospective propensity score matching study by Miao Wang, Han-Yu Cao, Kai-Wen Tan, Qiao-Cheng Qiu, Yuan-Hong Huang, Shuai-shuai Ge, Zi-Hao Wang, Jia Chen, Xiao-Wen Tang, De-Pei Wu, Sheng-Li Xue, Zheng Li, Hai-Ping Dai

Get full text

Venetoclax with hypomethylating agents versus intensive chemotherapy in newly diagnosed acute myeloid leukemia with myelodysplasia related changes: A propensity score-matched analy... by Chao-Ling Wan, Yu-Qing Liu, Fang-Tong Liu, Yuan-Hong Huang, Han-Yu Cao, Si-Man Huang, Kai-Wen Tan, Shuai-Shuai Ge, Miao Wang, Mei-Jing Liu, Zi-Hao Wang, Zheng Li, Sheng-Li Xue, Hai-Ping Dai

Get full text

Multiomic single cell sequencing identifies stemlike nature of mixed phenotype acute leukemia by Cheryl A. C. Peretz, Vanessa E. Kennedy, Anushka Walia, Cyrille L. Delley, Andrew Koh, Elaine Tran, Iain C. Clark, Corey E. Hayford, Chris D’Amato, Yi Xue, Kristina M. Fontanez, Aaron A. May-Zhang, Trinity Smithers, Yigal Agam, Qian Wang, Hai-ping Dai, Ritu Roy, Aaron C. Logan, Alexander E. Perl, Adam Abate, Adam Olshen, Catherine C. Smith

Get full text

Safe and potent anti‐CD19 CAR T‐cells with shRNA‐IL‐6 gene silencing element in patients with refractory or relapsed B‐cell acute lymphoblastic leukemia by Jin‐Feng Ma, Jia‐Wei Yan, Mei‐Jing Liu, Chun‐Long Yan, Xiao‐Wen Tang, Hui‐Ying Qiu, Miao Miao, Yue Han, Li‐Min Li, Li‐Qing Kang, Nan Xu, Zhou Yu, Jing‐Wen Tan, Hong‐Jia Zhu, Xu Jia, Zhi‐Zhi Zhang, Miao Wang, Hai‐Ping Dai, Lei Yu, Sheng‐Li Xue, De‐Pei Wu, Wen‐Jie Gong

Get full text